Stockreport

BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001

BIOCORRX INC NEW  (BICX) 
NASDAQ:AMEX Investor Relations: ir.biocorrx.com
PDF ANAHEIM, CA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- VDM-001 represents potential alternative to naloxone for overdose reversal; Potential to reduce cravings from substa [Read more]